Related Experiment Video
Updated: Jul 17, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy
T Andrew Burrow1, Mitchell B Cohen, Ronald Bokulic
1Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
Abstract:
A 5-year-old male with Gaucher's disease type 3 developed progressive mesenteric and mediastinal lymphadenopathy over 12 months, despite enzyme replacement therapy, contributing to the development of a protein-losing enteropathy. These complications are unique, indicating poorly accessible, differentially responsive compartments in patients with Gaucher's disease who are receiving enzyme therapy.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
Esophageal Achalasia
Chronic Pancreatitis II: Collaborative Care
Assessment:
Lysosomal Hydrolases
Chronic Pancreatitis II: Pathophysiology

